Plus Therapeutics (PSTV) Return on Capital Employed Growth (3y) (2014 - 2026)
Plus Therapeutics (PSTV) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Plus Therapeutics |
34.26 Mn |
19.15 Mn |
- |
10,907.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
10,907.00 |
| Dec 31, 2025 |
-12,569.00 |
| Sep 30, 2025 |
-138,272.00 |
| Jun 30, 2025 |
-22,508.00 |
| Mar 31, 2025 |
130,553.00 |
| Dec 31, 2024 |
23,943.00 |
| Sep 30, 2024 |
57,549.00 |
| Jun 30, 2024 |
22,367.00 |
| Mar 31, 2024 |
76,737.00 |
| Dec 31, 2023 |
-54,251.00 |
| Sep 30, 2023 |
-27,785.00 |
| Jun 30, 2023 |
-42,324.00 |
| Mar 31, 2023 |
-23,949.00 |
| Dec 31, 2022 |
-13,281.00 |
| Sep 30, 2022 |
-563.00 |
| Jun 30, 2022 |
18,873.00 |
| Mar 31, 2022 |
5,957.00 |
| Dec 31, 2021 |
7,209.00 |
| Sep 30, 2021 |
9,702.00 |
| Jun 30, 2021 |
11,353.00 |
